Ingredient or product comparison
Subcutaneous vs Topical Administration: Bioavailability and Dosing
Subcutaneous injection delivers GHK-Cu directly into the interstitial space surrounding fibroblasts, bypassing the stratum corneum barrier that limits dermal penetration of topically applied peptides. Bioavailability for subcutaneous GHK-Cu is approximately 80
This source-based comparison does not add ratings or recommend a winner.
- Subcutaneous injection delivers GHK-Cu directly into the interstitial space surrounding fibroblasts, bypassing the stratum corneum barrier that limits dermal penetration of topically applied peptides. Bioavailability for subcutaneous GHK-Cu is approximately 80%, meaning most of the administered dose reaches target tissue. Compared to 15–20% for topical formulations, which must penetrate the lipid-rich epidermis before reaching the dermis where collagen synthesis occurs.
- The optimal subcutaneous dose for systemic collagen remodeling is 1–3 mg/kg bodyweight daily. For a 70 kg individual, this translates to 70–210 mg GHK-Cu per day, typically divided into two injections (morning and evening) to maintain steady plasma levels throughout the 24-hour remodeling cycle. Studies measuring hydroxyproline content in dermal punch biopsies found that doses below 1 mg/kg produced minimal collagen increase above baseline, while doses above 3 mg/kg showed no statistically significant improvement over the 2–3 mg/kg range.
- Topical application requires higher concentrations to compensate for lower bioavailability. Formulations containing 0.05–0.1% GHK-Cu (500–1000 μg/mL) applied twice daily achieve dermal tissue concentrations comparable to 1–2 mg/kg subcutaneous dosing. Higher topical concentrations (0.2% or above) don't proportionally increase dermal penetration. The stratum corneum acts as a saturable barrier, and excess peptide remains on the skin surface or is absorbed into the epidermis without reaching fibroblast-dense dermis.
- We've found that combination protocols. Subcutaneous administration for systemic remodeling plus targeted topical application for localized photoaging or scarring. Produce superior results in research models compared to either route alone. The key is understanding that subcutaneous dosing establishes baseline collagen turnover across all tissues, while topical dosing allows site-specific concentration increases in areas requiring accelerated remodeling.